Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.89
+0.18 (1.54%)
At close: Aug 21, 2026, 4:00 PM EDT
11.74
-0.15 (-1.26%)
After-hours: Aug 21, 2026, 4:28 PM EDT

Kura Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-296.78-278.67-173.98-152.63-135.84-130.47
Depreciation & Amortization
1.291.030.850.850.760.56
Loss (Gain) From Sale of Investments
-4.95-8.49-13.14-9.421.614.39
Stock-Based Compensation
38.9437.1133.928.0826.3223.58
Other Operating Activities
0.460.520.520.480.070.61
Change in Accounts Receivable
-4.87-6.74-2.06---
Change in Inventory
-2.49-0.41----
Change in Accounts Payable
1.644.5-1.63-0.92-0.8-2.52
Change in Unearned Revenue
152.15195.72278.18---
Change in Other Net Operating Assets
2.84-8.6211.688.74-2.18-0.71
Operating Cash Flow
-111.76-64.06134.32-124.82-110.06-104.55
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5.67-6.64-0.47-0.17-0.63-1.15
Investment in Securities
103.02-6.46-101.1215.7333.25-125.69
Investing Cash Flow
97.35-13.1-101.5915.5632.63-126.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----10-
Long-Term Debt Repaid
------7.25
Net Debt Issued (Repaid)
----10-7.25
Issuance of Common Stock
2.71.79154.4294.7829.144.43
Other Financing Activities
-----0.58-0.61
Financing Cash Flow
2.71.79154.4294.7838.57-3.44

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-11.71-75.36187.14-14.48-38.87-234.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-117.43-70.7133.85-124.99-110.69-105.7
Free Cash Flow Growth
------
Free Cash Flow Margin
-152.06%-104.76%248.40%---
Free Cash Flow Per Share
-1.33-0.811.55-1.71-1.65-1.59
Levered Free Cash Flow
-165.88-141.73-55.93-63.9-63.67-60.41
Unlevered Free Cash Flow
-164.99-140.78-54.92-62.93-63.53-60.15

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
111.11.060.070.78
Change in Working Capital
149.27184.44286.177.82-2.98-3.22
SEC Filings: 10-K · 10-Q